Abundant Expression of Vasoactive Intestinal Polypeptide Receptor VPAC2 mRNA in Human Skin

This publication has 12 references indexed in Scilit:

• Vasoactive Intestinal Polypeptide Inhibits the Established Allergic Contact Dermatitis in Humansa
  Annals of the New York Academy of Sciences, 2006
• Expression and Distribution of Vasoactive Intestinal Polypeptide Receptor VPAC2 mRNA in Human Airways
  Laboratory Investigation, 2001
• Localization of the Peptide Transporter PEPT2 in the Lung
  The American Journal of Pathology, 2001
• VIP and PACAP: very important in pain?
  Trends in Pharmacological Sciences, 1999
• Evidence for an esophageal origin of VIP-IR and NO synthase-IR nerves innervating the guinea pig trachealis: A retrograde neuronal tracing and immunohistochemical analysis
  Journal of Comparative Neurology, 1998
• The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation
  Advances in Neuroimmunology, 1996
• The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high-performance liquid chromatography
  Clinical and Experimental Dermatology, 1994
• Increased sensory neuropeptides in nodular prurigo: a quantitative immunohistochemical analysis
  British Journal of Dermatology, 1992
• Immunohistochemical, morphological and functional changes in the peripheral sudomotor neuro-effector system in elderly people
  Journal of the Autonomic Nervous System, 1992
• Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes.
  Proceedings of the National Academy of Sciences, 1989